KLK6 and gastric cancer: Besides, kallikrein-related peptidase 6 (KLK6), a biomarker of GC associated with poor prognosis, could induce chemotherapeutic resistance by attenuating auranofin-induced cell death via an activation of autophagy in GC [11].